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 1. Abstract 
 
Background: Obesity is a risk factor for chronic venous insufficiency and venous 
thromboembolism. Aim of this study was to compare venous flow parameters of the 
lower limbs assessed by duplex scan in obese and non-obese subjects.  
 
Methods:  Venous hemodynamic was studied in non-obese (BMI <25 kg/m2) and 
obese (BMI>30 kg/m2) subjects by color-coded duplex sonography. Diameter, flow 
volume, peak, mean and minimum velocities were assessed in the femoral vein.    
 
Results: 46 non-obese limbs (23 subjects) and 44 obese limbs (22 subjects) were 
examined. Diameter of the femoral vein was significantly greater in obese compared 
to non-obese subjects (8.5 ± 2.2 mm versus 7.1 ± 1.6 mm, p= 0.0009). Venous peak 
and minimum velocities differed between non-obese and obese subjects (14.8 ± 7.2 
cm/s vs. 10.8 ± 4.8 cm/s, p=0.0071 and - 4.0 ± 3.6 cm/s versus 1.7 ± 6.3 cm/s, 
p=0.056). Calculation of venous amplitude and shear stress showed significantly 
higher values in non-obese compared to obese subjects (18.8 ± 9.4 cm/s versus 12.5 
± 9.3 cm/s, p=0.003 and 2.13 ± 2.2 dyn/cm2 versus 1.6 ± 2.7 dyn/cm2, p=0.03). 
Spearman rank correlation revealed a significant inverse correlation between waist-
to-hip ratio as well as the waist circumference and venous peak velocity, mean 
velocity, velocity amplitude (peak velocity – minimum velocity) and shear stress. 
 
Conclusion: Lower limb venous flow parameters differ significantly between healthy 
obese and non-obese subjects. These findings support the mechanical role of 
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abdominal adipose tissue potentially leading to elevated risk for both venous 
thromboembolism and chronic venous insufficiency. 
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2. Introduction  
 
Several epidemiological studies have given strong advice to the hypothesis that 
obesity is a risk factor for both chronic venous insufficiency (CVI) and venous 
thromboembolism (VTE).1-3 Obesity plays a key role in the development of metabolic 
syndrome with a cluster of cardiovascular risk factors.4 Excess body weight has also 
been related to various alterations in the coagulation system including impaired 
fibrinolytic activity and elevated plasma concentrations of clotting factors.5 These 
alterations in endothelial function and coagulation are thought not only to be relevant 
for arterial but also for venous thrombosis. 6 In addition to these mechanisms, obesity 
is thought to predispose venous stasis, which is a trigger of both deep VTE and CVI. 
Central abdominal obesity is thought to be associated with an increased 
intraabdominal pressure (IAP) caused by abdominal fat.7-9 Arvfidsson and coworkers 
showed that the pressure in the iliofemoral vein in morbidly obese patients is 
significantly higher compared to non-obese subjects. 8 Likewise, it has been shown 
that surgical weight reduction decreases urinary bladder pressure, a surrogate maker 
of IAP.9 
Elevated IAP therefore might impede venous backflow in the iliofemoral veins 
resulting in venous stasis and vein distension of the lower limbs favouring valve 
dysfunction and thrombosis. To our knowledge there are no human in-vivo studies 
aimed at proving this assumption. Color-coded duplex sonography (CCDS) allows a 
non-invasive and accurate flow assessment of the veins of the lower limbs.10 We 
hypothesized that venous flow characteristics of the lower limbs differ between obese 
and non-obese subjects inasmuch as obese subjects exhibit lower flow velocities and 
larger vein diameter and that abdominal obesity correlates with venous hemodynamic 
changes. 
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3. Methods 
 
Subjects and Study Protocol 
Venous hemodynamic of the lower limbs was studied in 46 limbs of non-obese (BMI 
< 25 kg/m2) and 44 limbs of obese (BMI >30 kg/m2) otherwise healthy subjects. 
Inclusion criteria were either BMI < 25 kg/m2 or >30 kg/m2. Exclusion criteria were 
clinical signs of CVI, duplex sonographic evidence of venous valve dysfunction or 
outflow obstruction, prior limb surgery or sclerotherapy, history or clinical signs of 
arterial disease, connective tissue disorders, leg trauma or swelling, clinical signs of 
lymphedema, history of chronic obstructive pulmonary disease and cardiac failure. 
The protocol entailed patient history, clinical examination and duplex sonography to 
exclude venous incompetence or thrombosis. The local ethic committee of the 
University Hospital of Zurich approved the study (EK 1709) and all patients gave 
written informed consent. Medical staff and students volunteered as study 
participants. 
 
Body Mass Index and Waist-to-Hip Ratio 
BMI was calculated from measured patients height and weight using the following 
equation: BMI = kg/m2. 
Waist circumference was measured at a point midway between the costal margin and 
iliac crest and in line with mid-axilla. To measure hip circumference the greater 
trochanter was located as the widest part of the hips at the level of buttock line. Both 
waist and hip circumference were assessed in upright position. Afterwards the waist-
to-hip-ratio (WHR) was calculated. 
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Color-coded duplex sonography (CCDS) 
Duplex assessments were performed in the vascular laboratory of a tertiary referral 
hospital by experienced vascular physicians. Standardized supine position was 
applied for all duplex scan measurements with subjects in upper body elevation of 
100.  
CCDS was performed by using the Accuson Sequoia 512 (Siemens AG, Medical 
Solutions, Zurich, Switzerland) with a 8 MHz linear scan head. The technical settings 
(gain, contrast, rejection) were optimized after initial evaluation and maintained 
constant. Real time gated Doppler superimposed on B mode imaging was used for 
flow measurements. Signals representing artefacts due to erratic movements or 
forced breathing were discarded and measurements repeated. 
Doppler flow velocity tracings representing time-periods of 7s were stored and 
processed using automated wave form-enveloping duplex. 
Flow was studied at the femoral vein 2 cm caudal to the confluence with the deep 
femoral vein. Peak [PeakV], mean [MeanV] and minimum [MinV] velocities were 
obtained. Vein diameter was measured by placing the B mode callipers over the 
proximal and distal intimal-luminal interfaces. Cross-sectional area was calculated 
from π x Diameter²/4. Its calculation enabled the estimation of venous volume flow 
[Qvenous = MeanV x cross-sectional area]. Pulsatility index of venous flow 
[PIvenous] was calculated as follows: PIvenous = (Vpeak–Vmin)/Vmean in keeping 
with its estimation in arterial flow.11 The velocity amplitude (Vamp) was calculated 
from the difference between PeakV-MinV. At least 4 measurements were performed 
for each one of the evaluated parameters and then averaged. Venous wall shear 
stress was calculated from 8 x µ x Vmean/diameter where blood viscosity (µ) was 
assumed to be constant at 0.035 dyn·s–1·cm–2.12  
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The applied method´s reproducibility for the estimated flow in smaller veins such as 
perforators has been reported 13 as well as validation and reproducibility of this 
automatic method have been described previously.10 
 
Statistical analysis 
Data were expressed as mean and standard deviations and analyzed with the Mann-
Whitney-U test for intergroup comparison between obese and non-obese subjects. 
Correlations between WHR/ waist circumference and venous flow parameters were 
calculated by Spearman rank test. We did not correlate BMI with flow parameters 
because BMI was used to differentiate between obese and non-obese subjects and 
was not a continuous variable since overweight subjects (BMI 25-29 kg/m2) were not 
included. Statistical analysis was performed using the software SPSS 13.  A p-value 
<0.05 was considered to be significant.  
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4. Results 
 
All assessed 46 limbs of non-obese (= control) and 44 limbs of obese subjects were 
included in the analyses. Baseline characteristics are shown in table 1. 
 
Table 1. Baseline characteristics of control and obese subjects 
  
Controls 
 
Obese 
 
P* 
 (n = 23) (n = 22)  
 
Female 
 
10 
 
10 
 
1.0 
Age 49.7 (15.6) 53.5 (15.5) 0.013 
Weight (kilograms) 69 (10) 106 (18) <0.0001 
Height (meters) 1.75 (0.08) 1.71 (0.1) 0.2700 
Body Mass Index (kg/meter2) 22.4 (2.1) 36.2 (5.9) <0.0001 
Waist circumference (cm) 88 (10) 122 (11) <0.0001 
Hip circumference (cm) 93 (5) 114 (11) <0.0001 
Waist-to-Hip Ratio (WHR) 0.94 (0.07) 1.08 (0.07) <0.0001 
All values are mean and standard deviations, * Mann Whitney-U test 
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Obesity, hemodynamics and venous diameter   
PeakV was significantly higher in non-obese (14.8  7.2 cm/s) compared to obese 
subjects (10.8  4.8cm/s, p= 0.0070) (Figure 1). MinV tended to be lower in control 
subjects (-4.0  3.6 cm/s versus -1.7  6.3 cm/sec in obese, p= 0.056) (Figure 1). 
Obesity did not impact MeanV (control subjects 4.8  5.1 versus 3.8  3.5 in obese 
subjects, p = 0.239) (Figure 1). Diameter of the femoral vein was significantly smaller 
in the control group (7.1  1.6 mm) compared to obese subjects (8.5  2.2 mm, p = 
0.0009). No significant difference of the flow volume was found between both groups 
(controls 89.5  81.5 ml/min, obese 99.4  54.7 ml/min, p= 0.12). There were no 
significant differences between left and right lower limb for all assessed and 
calculated flow parameters (PeakV, MinV, MeanV, diameter, Qvenous, PIvenous, 
PeakV-MinV) for each group (data not shown). 
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Obesity and outflow resistance / Obesitiy and shear stress 
Pulsatility index indicating outflow resistance was significantly higher in obese 
subjects (7.24  2.3) than in the control group (5.99  0.86; p = 0.02) (Figure 2). 
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Velocity amplitude (PeakV-MinV) was significantly higher in the control group (18.8  
9.4 cm/s) compared to obese subjects (12.5  9.3 cm/s, p = 0.003) (Figure 3). 
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Lower mean velocities and greater diameters result in a lower wall shear stress in 
obese subjects which was 1.2  0.0 dyn/cm2 versus 2.13  2.2 dyn/cm2 in non-obese 
subjects (p = 0.0172) (Figure 4).  
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Correlation between abdominal obesity and hemodynamic parameters 
Spearman rank correlation revealed a significant inverse correlation between WHR or 
waist circumference and PeakV, MeanV, velocities amplitude (PeakV-MinV) and 
shear stress. Furthermore there was a significant positive correlation between 
WHR/waist circumference for MinV and diameter (Table 2). No significant 
correlations were found for WHR, pulsatility index and volume flow. However the 
similar inverse, positive correlations and lack of correlation respectively were found 
when only waist circumference was taken as an independent factor.  
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Table 2. WHR and waist circumference in correlation to lower limb venous flow 
characteristics in 22 obese and 23 non-obese subjects 
 
Parameters R* P  
Waist-to-Hip ratio (WHR)   
 Peak Velocity -0.44 < 0.0001 
 Minimum Velocity 0.429 < 0.0001 
 Mean Velocity -0.294 0.0084 
 Peak-Minimum Velocity -0.533 < 0.0001 
 Pulsatility Amplitude -0.197 0.0768 
 Diameter 0.458 < 0.0001 
 Volume Flow 0.093 0.4057 
 Shear Stress -0.413 0.0002 
Waist circumference   
 Peak Velocity -0.378 0.0007 
 Minimum Velocity 0.314 0.0050 
 Mean Velocity -0.25 0.0247 
 Peak-Minimum Velocity -0.428 0.0001 
 Pulsatility Amplitude -0.153 0.168 
 Diameter 0.456 <0.0001 
 Volume Flow 0.143 0.2031 
 Shear Stress -0.369 0.0009 
 * Spearman rank correlation 
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5. Discussion  
 
The results of the present study suggest that obesity impacts lower limb venous 
properties. Diameter of the femoral vein was significantly greater in obese compared 
to non-obese subjects. This could be interpreted as a result of elevated IAP 
transmitted to the femoral veins and leading to vein wall extension. Increased stasis 
and reduced forward flow velocity might be a consequence. Indeed, we also found 
significant different hemodynamic properties between obese and non-obese 
subjects. PeakV was lower and MinV higher in the obese group most probably due to 
elevated IAP which results from abdominal fat causing outflow obstrution. Likewise, 
pulsatility index which is derived from peak, minimum and mean venous flow 
velocities indicates a higher outflow resistance in obese subjects in our study. 
 Lower amplitude between peak and minimum venous velocities in obese subjects 
indicates a continuous flow. This is in agreement with the greater vein diameter found 
in the obese group and previous reports on intravenous pressure in obese subjects 
which is greater compared to non-obese subjects.7-9 Abdominal obesity increases 
IAP which is transmitted to the veins of the lower limbs. This leads to greater tension 
on the venous vessel wall and hence greater diameters. Minimum venous velocity is 
usually slightly negative since venous valves close due to backflow. Although one 
might expect higher venous backflow in obese subjects our data indicates the 
opposite. It seems more likely that through the greater pressure venous vessel wall is 
permanently under greater tension in obese people and hence venous elasticity is 
attenuated. This potentially results in venous valve dysfunction over time and might 
explain the higher incidence of venous insufficiency in obese people.14 The 
significantly lower venous shear stress in the obese group support that increased IAP 
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in obese subjects results in venous stasis of the lower limb given by correlation 
between WHR or waist circumference with velocity parameters and diameter.  
We used BMI for group definition (obese versus non-obese subjects) since this 
marker of overweight and obesity is established and correlates well with total body fat 
content in adults.15 However, this marker fails considering the distribution of fat.16 In 
view of the relationship between central obesity and coronary heart disease waist 
circumference and WHR are accepted. We therefore used these two parameters 
since this considers abdominal fat distribution.  
Our data show a significantly lower value of shear stress at the femoral vein in obese 
compared to non-obese subjects. Laminar shear stress can promote the release of 
factors reducing inflammation and the formation of reactive free radicals while low or 
zero shear stress can promote the opposite.17 And as furthermore described by 
Bergan et al. decreased shear stress might support development of chronic venous 
insufficiency.17 In addition, these alterations of inflammation and coagulation at the 
venous endothelium are further enhanced by systemic changes in these parameters 
which in addition to chronic venous insufficiency favour a thromboembolic event. 
Whereas there are only few reports on human in-vivo assessment of venous flow 
properties there are abundant studies showing that obesity increases among other 
intrinsic factors such as previous VTE, venous insufficiency, chronic heart failure, 
immobility and cancer the likelihood for an adverse event. 18 Numerous studies have 
shown a clear relationship between obesity and the risk of idiopathic VTE and 
pulmonary embolism independent of other recognised risk factors with odds ratios of 
2.42 in two separate studies comparing BMI >30 kg/m2 with BMI <25 kg/m2.6,15,19,20 
Even more striking is the fact that waist circumference exceeding 100cm confers up 
to a 4-fold increased risk of venous thromboembolism.19,21 Likewise, obese patients 
are more likely to develop the post-thrombotic syndrome following VTE.1 Excess 
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body weight is not only a risk factor for a first VTE event but also for recurrent VTE 
events as recently reported.22 
Many researches in this field focused on changes in coagulation and reported that 
levels of D-dimer, fibrinogen, factor VIII and factor IX are significantly increased 
according to categories of BMI. Interestingly, stasis as a third factor in the Virchow’s 
Triad has not been as extensively assessed in human in-vivo study. There are 
invasive human in-vivo studies that investigated the effect of abdominal obesity on 
IAP and intravenous iliac pressure.8,9 These studies required either a venous access 
or a bladder catheter. In contrast CCDS is non-invasive and allows an assessment of 
flow patterns. Fronek et al. have used CCDS to investigate the effect of aging on 
lower limb venous hemodynamic. 23 Delis et al. used CCDS scan in the assessment 
of venous hemodynamic of perforator veins as well as to determine the effect of 
posture on deep vein flow patterns.10,13  
Although we studied a rather small group of obese and non-obese subjects the 
findings are striking considering the limited number of examined lower limbs and 
underline that abdominal obesity is associated with lower limb outflow impairment.  
Our study sample is too limited to stratify venous flow impairment for categories of 
BMI. Furthermore it does not allow drawing any conclusion on venous velocities in 
patients with moderate overweight (BMI 25-30 kg/m2). Our data only indicates that an 
impairment of lower limb venous outflow is observed in obese subjects but not 
whether this might be translated into an increased risk for VTE or CVI. This link has 
recently been reported by larger, event-driven cohort studies18, 19, 21, 22. However 
other factors such ambulatory activity, ankle-joint function and gait pattern might play 
a role as well.  
The non-blinded manner of data assessment by duplex sonography must be 
considered as a shortcoming in our study protocol. Blinding the observer was 
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impossible in our study setting. Measurements were strictly standardized to 
overcome it. This standardization and the applied exclusion criteria were also needed 
to minimize the impact of other factors that might affect venous flow like movements, 
posture or respiration pattern.  
We found no differences between the right and left limb regarding the assessed 
duplex sonographic hemodynamic direct and indirect parameters (data not shown). It 
has been shown that iliac vein compression is much more prevalent in women than in 
men 24. Of course it would have been interesting to provide more precise information 
about the venous system of the included subjects in our trial, i.e. by means of venous 
pressure measurements, plethysmography and abdominal CT scanning. 
Nevertheless, our data indicates that a simple, non-invasive assessment by means of 
duplex sonography is sufficient to detected differences in flow patterns with respect to 
obesity. Although, there was no matching for age between obese and non-obese 
subjects. We cannot exclude this as a possible confounder even if it does not seem 
very likely.   
In conclusion, our findings support the hypothesis that obesity has a relevant 
influence on lower limb venous hemodynamic parameters. If this may explain the 
increased risk for chronic venous insufficiency and venous thromboembolism in 
obese subjects remains speculative and should be further investigated.  
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